首页 > 最新文献

Medicom Conference Report ASH 2023最新文献

英文 中文
Undetectable MRD on maintenance venetoclax, acalabrutinib, and obinutuzumab in the majority of R/R CLL participants 大多数 R/R CLL 参与者在接受 Venetoclax、acalabrutinib 和 obinutuzumab 治疗后,MRD 检测不到
Pub Date : 2024-02-07 DOI: 10.55788/11dff369
Robert van den Heuvel
{"title":"Undetectable MRD on maintenance venetoclax, acalabrutinib, and obinutuzumab in the majority of R/R CLL participants","authors":"Robert van den Heuvel","doi":"10.55788/11dff369","DOIUrl":"https://doi.org/10.55788/11dff369","url":null,"abstract":"","PeriodicalId":517344,"journal":{"name":"Medicom Conference Report ASH 2023","volume":"23 20","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139893344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term efficacy and safety of iptacopan in PNH with anaemia 伊帕考潘对伴有贫血的 PNH 的长期疗效和安全性
Pub Date : 2024-02-07 DOI: 10.55788/a06f74c6
Robert van den Heuvel
{"title":"Long-term efficacy and safety of iptacopan in PNH with anaemia","authors":"Robert van den Heuvel","doi":"10.55788/a06f74c6","DOIUrl":"https://doi.org/10.55788/a06f74c6","url":null,"abstract":"","PeriodicalId":517344,"journal":{"name":"Medicom Conference Report ASH 2023","volume":"18 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139895353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Momelotinib beats controls regarding transfusion outcomes in myelofibrosis 在骨髓纤维化患者输血效果方面,莫米替尼优于对照组
Pub Date : 2024-02-07 DOI: 10.55788/195a47af
Robert van den Heuvel
{"title":"Momelotinib beats controls regarding transfusion outcomes in myelofibrosis","authors":"Robert van den Heuvel","doi":"10.55788/195a47af","DOIUrl":"https://doi.org/10.55788/195a47af","url":null,"abstract":"","PeriodicalId":517344,"journal":{"name":"Medicom Conference Report ASH 2023","volume":"126 3-4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139895533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel risk assessment model acts on increasing hospital-acquired venous thromboembolism rates among children 新型风险评估模型有助于提高儿童的医院获得性静脉血栓栓塞率
Pub Date : 2024-02-07 DOI: 10.55788/e518c218
Robert van den Heuvel
{"title":"Novel risk assessment model acts on increasing hospital-acquired venous thromboembolism rates among children","authors":"Robert van den Heuvel","doi":"10.55788/e518c218","DOIUrl":"https://doi.org/10.55788/e518c218","url":null,"abstract":"","PeriodicalId":517344,"journal":{"name":"Medicom Conference Report ASH 2023","volume":"61 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139895515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blinatumomab reduces toxicity in the consolidation phase in paediatric high-risk B-cell ALL Blinatumomab可降低儿科高危B细胞ALL巩固治疗阶段的毒性
Pub Date : 2024-02-07 DOI: 10.55788/19866a5c
Robert van den Heuvel
{"title":"Blinatumomab reduces toxicity in the consolidation phase in paediatric high-risk B-cell ALL","authors":"Robert van den Heuvel","doi":"10.55788/19866a5c","DOIUrl":"https://doi.org/10.55788/19866a5c","url":null,"abstract":"","PeriodicalId":517344,"journal":{"name":"Medicom Conference Report ASH 2023","volume":"277 12","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139896072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TRANSFORM-1: High spleen volume reduction rates for navitoclax plus ruxolitinib in myelofibrosis TRANSFORM-1:纳维替克联合鲁索利替尼治疗骨髓纤维化的脾脏体积缩小率较高
Pub Date : 2024-02-07 DOI: 10.55788/3462662c
Robert van den Heuvel
{"title":"TRANSFORM-1: High spleen volume reduction rates for navitoclax plus ruxolitinib in myelofibrosis","authors":"Robert van den Heuvel","doi":"10.55788/3462662c","DOIUrl":"https://doi.org/10.55788/3462662c","url":null,"abstract":"","PeriodicalId":517344,"journal":{"name":"Medicom Conference Report ASH 2023","volume":"40 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139895346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Favourable QoL and bleeding outcomes for rilzabrutinib in ITP 利扎鲁替尼治疗ITP具有良好的QoL和出血疗效
Pub Date : 2024-02-07 DOI: 10.55788/2d100bb8
Robert van den Heuvel
{"title":"Favourable QoL and bleeding outcomes for rilzabrutinib in ITP","authors":"Robert van den Heuvel","doi":"10.55788/2d100bb8","DOIUrl":"https://doi.org/10.55788/2d100bb8","url":null,"abstract":"","PeriodicalId":517344,"journal":{"name":"Medicom Conference Report ASH 2023","volume":"2 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139896055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
DALIAH: Peginterferon-α head-to-head against hydroxyurea in MPN DALIAH:Peginterferon-α与羟基脲在骨髓增生性白血病中的正面交锋
Pub Date : 2024-02-07 DOI: 10.55788/38079b44
Robert van den Heuvel
{"title":"DALIAH: Peginterferon-α head-to-head against hydroxyurea in MPN","authors":"Robert van den Heuvel","doi":"10.55788/38079b44","DOIUrl":"https://doi.org/10.55788/38079b44","url":null,"abstract":"","PeriodicalId":517344,"journal":{"name":"Medicom Conference Report ASH 2023","volume":"29 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139895350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SYMPATICO: Ibrutinib plus venetoclax boosts PFS in R/R mantle cell lymphoma SYMPATICO:伊布替尼加venetoclax可改善R/R套细胞淋巴瘤的PFS
Pub Date : 2024-02-07 DOI: 10.55788/2e1c8f3f
Robert van den Heuvel
{"title":"SYMPATICO: Ibrutinib plus venetoclax boosts PFS in R/R mantle cell lymphoma","authors":"Robert van den Heuvel","doi":"10.55788/2e1c8f3f","DOIUrl":"https://doi.org/10.55788/2e1c8f3f","url":null,"abstract":"","PeriodicalId":517344,"journal":{"name":"Medicom Conference Report ASH 2023","volume":"95 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139895519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Axatilimab may present a new therapeutic strategy in chronic GvHD 阿沙替利单抗可能为慢性风湿性关节炎提供一种新的治疗策略
Pub Date : 2024-02-07 DOI: 10.55788/c1876370
Robert van den Heuvel
{"title":"Axatilimab may present a new therapeutic strategy in chronic GvHD","authors":"Robert van den Heuvel","doi":"10.55788/c1876370","DOIUrl":"https://doi.org/10.55788/c1876370","url":null,"abstract":"","PeriodicalId":517344,"journal":{"name":"Medicom Conference Report ASH 2023","volume":"111 3-4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139895535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medicom Conference Report ASH 2023
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1